Download ERINHA conference: launching the European Research

ERINHA conference: launching the European Research Infrastructure on Highly Pathogenic
Agents’ scientific strategy
A workshop for the scientific community and potential users
10th May 2017
Marriott Grand Place, Brussels, Belgium
0830-0900
Registration
SESSION 1
0900-0925
INTRODUCTION TO ERINHA
An Introduction to ERINHA
Dr Hervé Raoul
(ERINHA coordinator, Inserm)
ERINHA’s Scientific Strategy
Prof Miles Carroll
(PHE – Department of Health)
RESEARCH AFTER EBOLA
Current Diagnostics for Highly Pathogenic Agents
Dr Antonino di Caro
and Knowledge Gaps
(National Institute for Infectious
Diseases " Italy)
The Basic Research of Highly Pathogenic Agents in
Dr Ali Mirazimi
Europe
(Public Health Agendy Sweden)
Vaccine Research – Current and Future
Prof Roger Hewson
Perspectives
(Department of Health)
COFFEE
Antiviral Therapeutics for Highly Pathogenic
Dr Xavier de Lamballerie
Agents
(Aix Marseille University)
PARTNERSHIPS AND FUNDING OPPORTUNITIES
The Role of Public/Private Partnerships to Ensure
Dr Jean Lang
Global Health. The Industry’s Perspective on
(Sanofi Pasteur, IMI Infection Control)
Vaccine Development
The WHO Blueprint – Implications for future
Dr Bernadette Murgue
research
(WHO R&D Blueprint)
EU emerging disease laboratory preparedness and
Dr Marc Struelens
unmet public health needs
(ECDC)
LUNCH
Preparedness, Readiness and Response to Highly
Dr Sylvie Briand
Pathogenic Agents
(WHO)
Coalition for Epidemic Preparedness Innovations
Dr Richard Hatchett
(CEPI)
Funding Opportunities for Highly Infectious
Ms Magda Chlebus
Diseases - IMI
(EFPIA, IMI)
The European Role in Global Epidemics and
Dr Barbara Kerstiens
Funding for Highly Infectious Disease Research
(European Commission)
Project Bioshield
Dr Michael Merchlinsky (BARDA)
COFFEE
ERINHA – The Future
The ERINHA approach and access modalities
Dr Caroline Carbonnelle
(Inserm, France)
ERINHA – The next steps
Dr Hervé Raoul / Director General
CLOSE
0925-0950
SESSION 2
0950-1015
1015-1040
1040-1115
1115-1145
1145-1210
SESSION 3
1210-1230
1230-1255
1255-1310
1310-1400
1400-1425
1425-1450
1450-1515
1515-1540
1540-1605
1605-1630
SESSION 4
1630-1655
1655-1730
1730